B420 + Litesse
Natural health product licensed in Canada
- Licence holder
- Danisco USA Inc.
- NPN or DIN-HM
- 80084627
- Status
- Active licence
- Licence date
- 25 April 2018
- Revision date
- 31 January 2019
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 10 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : B420 | 10 Milliards d'UFC | Not calculated |
| Poly(dextrose) Source : Poly(dextrose) | 12 g | Not calculated |
Non-medicinal ingredients
Phosphate de dipotassium, Sucrose, Phosphate de potassium, monobasique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 packet | 1 day |
Uses authorised in Canada
Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management/maintenance program. Source of Probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Could possibly help to temporarily increase satiety/feelings of fullness when taken 90 minutes prior to a meal. Could possibly help to temporarily reduce food intake when taken 90 minutes prior to a meal.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have fever, vomiting, nausea, bloody diarrhea or severe abdominal pain, are taking medications which inhibit peristaltic movement (e.g. opiods, loperamide). If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. If you experience chest pain or difficulty breathing after taking this product, consult a health care practitioner immediately. Do not use this product if you are pregnant or breastfeeding, have difficulty swallowing or have diabetes or an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). May cause gastrointestinal disturbances.
Source
Official Health Canada record, licence 80084627
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging